Thomas Scheper
Overview
Explore the profile of Thomas Scheper including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
223
Citations
1903
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Patrikiou E, Efthymiou G, Liaskos C, Ntavari N, Scheper T, Meyer W, et al.
Immunol Res
. 2024 Dec;
73(1):22.
PMID: 39702701
Helicobacter pylori (Hp) has been postulated as an infectious trigger of psoriatic disease, namely psoriasis (Ps) and psoriatic arthritis (PsA), but meticulous antibody (ab) reactivity against all dominant and subdominant...
2.
Venkataraman I, Ott A, Miske R, Scharf M, Schulz A, Scheper T, et al.
Neurology
. 2024 Oct;
103(7_Supplement_1):S78-S79.
PMID: 39378381
Objective: Here, we assess the performance of the new EUROLINE Neurologic Syndrome 15 Ag (IgG) which expands the EUROLINE Paraneoplastic Neurologic Syndrome 12 Ag by adding CDR2L (together with CDR2...
3.
Barlas F, Olceroglu B, Ag Seleci D, Gumus Z, Siyah P, Dabbek M, et al.
Cancer Med
. 2024 Aug;
13(15):e70079.
PMID: 39118454
Background: Cancer remains a formidable global health challenge, currently affecting nearly 20 million individuals worldwide. Due to the absence of universally effective treatments, ongoing research explores diverse strategies to combat...
4.
Lindenhahn P, Richter J, Pepelanova I, Seeger B, Volk H, Hinkel R, et al.
Biomimetics (Basel)
. 2024 Apr;
9(4).
PMID: 38667208
Background: Experimental coronary artery interventions are currently being performed on non-diseased blood vessels in healthy animals. To provide a more realistic pathoanatomical scenario for investigations on novel interventional and surgical...
5.
Heuer C, Jiang X, Ron G, Ternyak O, Scheper T, Bahnemann J, et al.
Chem Commun (Camb)
. 2024 Jan;
60(10):1305-1308.
PMID: 38197155
We present the application of a photonic silicon chip-based optical sensor system for expeditious and phenotypic antifungal susceptibility testing. This label-free diagnostic assay optically monitors the growth of at varying...
6.
Schellenberg J, Dehne M, Lange F, Scheper T, Solle D, Bahnemann J
Bioengineering (Basel)
. 2023 Jun;
10(6).
PMID: 37370588
Monoclonal antibodies are increasingly dominating the market for human therapeutic and diagnostic agents. For this reason, continuous methods-such as perfusion processes-are being explored and optimized in an ongoing effort to...
7.
Wohlenberg O, Kortmann C, Meyer K, Scheper T, Solle D
Eng Life Sci
. 2023 Feb;
23(2):e202200056.
PMID: 36751474
Quality by Design (QbD) is one of the most important tools for the implementation of Process Analytical Technology (PAT) in biopharmaceutical production. For optimal characterization of a monoclonal antibody (mAb)...
8.
Heuer C, Preuss J, Buttkewitz M, Scheper T, Segal E, Bahnemann J
Lab Chip
. 2022 Nov;
22(24):4950-4961.
PMID: 36412200
With antimicrobial resistance becoming a major threat to healthcare settings around the world, there is a paramount need for rapid point-of-care antimicrobial susceptibility testing (AST) diagnostics. Unfortunately, most currently available...
9.
Wohlenberg O, Kortmann C, Meyer K, Schellenberg J, Dahlmann K, Bahnemann J, et al.
Eng Life Sci
. 2022 Jul;
22(7):484-494.
PMID: 35865649
Quality by Design principles are well described and widely used in biopharmaceutical industry. The characterization of a monoclonal antibody (mAb) production process is crucial for novel process development and control....
10.
Kraus X, van de Flierdt E, Renzelmann J, Thoms S, Witt M, Scheper T, et al.
Microvasc Res
. 2022 Jun;
143:104402.
PMID: 35753506
In regenerative medicine, autologous peripheral blood derived endothelial colony forming cells (PB-derived ECFC) represent a promising source of endothelial cells (EC) for pre-endothelialization of arterial tissue engineered vascular grafts (TEVG)...